Scientists at MD Anderson Cancer Center have revealed how ATRX mutations restructure chromatin and activate oncogenic ...

A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in ...

HOUSTON, JULY 1, 2026 ― A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...

Signal transduction and gene regulation are at the heart of cell and developmental biology, driving cell fate decisions and tissue homeostasis. In cancer, ...

Michigan State University researchers have identified how ovarian cancer cells become resistant to chemotherapy and ...

DNA carries the instructions for life, but additional molecular systems help determine how those instructions are used. New ...

A Boston biotech company has administered what researchers are describing as the first human dose of a cellular rejuvenation drug, a milestone in the effort to treat age-related disease at the ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

First human gets experimental gene shot to rewind ageing cells in the eye Life Biosciences has dosed its first patient with ER-100, a treatment that uses partial cellular reprogramming to target ...

The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a prescription that will make you 10 years younger. Now MIT Technology Review has ...

In a breakthrough for longevity science, a reverse-aging treatment has been injected into a human. The technique is a sought-after solution for improving longevity by reprogramming cells. Competitors ...

For Beijing-based METiS TechBio CEO Lai Tsai-ta, ageing is comparable to bugs building up in a complex software system – it happens once errors begin to accumulate in the genetic code of human cells, ...